Determination of cefcapene acid by LC-MS and their application to a pharmacokinetic study in healthy Chinese volunteers

被引:1
作者
Duan, Hong-Fei [1 ]
Ding, Li [1 ]
Li, Xiao-Bing [1 ]
Hu, Lin-Lin [1 ]
Wen, Ai-Dong [2 ]
Leng, Ye [1 ]
Liu, Zhen [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut Anal, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
[2] Fourth Mil Med Univ PLA, Affiliated Hosp 1, Dept Pharm, Xian 710032, Shaanxi, Peoples R China
关键词
Cefcapene acid; Cefcapene pivoxil; LC-MS; Human plasma; Urine; Pharmacokinetics;
D O I
10.1016/j.jpha.2012.09.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Simple, rapid and specific liquid chromatography-mass spectrometry (LC-MS) methods have been developed and validated for the quantification of cefcapene acid in human plasma and urine. Plasma samples were simply pretreated with methanol for deproteinization. Urine samples were briefly diluted with methanol-water (50:50, v/v), and centrifuged to remove large particles. Chromatographic separation was performed on a Hedera ODS-2 column. For the plasma assay, the isocratic mobile phase consisted of 35% solvent A (Methanol) and 65% solvent B (10 mM ammonium acetate buffer solution containing 0.2% folic acid) with a flow rate of 0.3 mL/min. For the urine assay, the isocratic mobile phase consisted of 30% solvent A (Methanol) and 70% solvent B (10 mM ammonium acetate buffer solution containing 0.2% folic acid) with a flow rate of 0.3 mL/min. The assays were linear over the concentration ranges of 0.03-5 mu g/mL in plasma and 0.1-400 mu g/mL in urine, and were successfully applied to a pharmacokinetic study after single and multiple oral administrations of cefcapene pivoxil hydrochloride tablets in healthy Chinese volunteers. (C) 2013 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 17 条
[1]   HYDROLYSIS OF PIVAMPICILLIN IN BUFFER AND PLASMA SOLUTIONS - FORMATION OF A 4-IMIDAZOLIDINONE FROM AMPICILLIN AND FORMALDEHYDE [J].
BUNDGAARD, H ;
KLIXBULL, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (2-3) :175-183
[2]  
Chan C. C., 2004, ANAL METHOD VALIDATI, DOI DOI 10.1002/0471463728
[3]  
Fujii R, 1995, Jpn J Antibiot, V48, P921
[4]   Pharmacokinetics of cefcapene pivoxil and AS-924 in gastrectomized patients [J].
Fujimoto, M .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (05) :489-494
[5]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 7-BETA-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-3-(SUBSTITUTED)-2-PROPENOYLAMINO]-3-CEPHEMS WITH C-3 SUBSTITUTIONS [J].
ISHIKURA, K ;
KUBOTA, T ;
MINAMI, K ;
HAMASHIMA, Y ;
NAKASHIMIZU, H ;
MOTOKAWA, K ;
KIMURA, Y ;
MIWA, H ;
YOSHIDA, T .
JOURNAL OF ANTIBIOTICS, 1994, 47 (04) :466-476
[6]   SPECTROPHOTOMETRIC DETERMINATION OF THE RATES OF HYDROLYSIS OF ALDEHYDE-RELEASING PRO-DRUGS IN AQUEOUS-SOLUTION AND PLASMA [J].
JOHANSEN, M ;
BUNDGAARD, H ;
FALCH, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 13 (01) :89-98
[7]   DISPOSITION OF S-1108, A NEW ORAL CEPHEM ANTIBIOTIC, AND METABOLIC-FATE OF PIVALIC ACID LIBERATED FROM [PIVALOYL-C-14]S-1108 IN RATS AND DOGS [J].
MIZOJIRI, K ;
FUTAGUCHI, S ;
NORIKURA, R ;
KATSUYAMA, Y ;
NAGASAKI, T ;
YOSHIMORI, T ;
NAKANISHI, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1445-1453
[8]   PHASE-I CLINICAL-STUDIES OF S-1108 - SAFETY AND PHARMACOKINETICS IN A MULTIPLE-ADMINISTRATION STUDY WITH SPECIAL EMPHASIS ON THE INFLUENCE ON CARNITINE BODY STORES [J].
NAKASHIMA, M ;
UEMATSU, T ;
OGUMA, T ;
YOSHIDA, T ;
MIZOJIRI, K ;
MATSUNO, S ;
YAMAMOTO, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :762-768
[9]   Rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of clonidine in human plasma [J].
Parekh, Sagar A. ;
Pudage, Ashutosh ;
Joshi, Santosh S. ;
Vaidya, Vilas V. ;
Gomes, Noel A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 867 (02) :172-178
[10]   STUDIES ON BETA-LACTAM ANTIBIOTICS FOR MEDICINAL PURPOSE .22. STUDIES ON THE METABOLISM OF PIVALOYLOXYMETHYL (6R,7R)-7-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO]-3-[(5-METHYL-2H-TETRAZOL-2-YL)METHYL]-3-CEPHEM-4-CARBOXYLATE (T-2588) .2.E [J].
SAIKAWA, I ;
NAKAJIMA, Y ;
TAI, M ;
SAKAI, H ;
DEMACHI, K ;
KAJITA, T ;
HAYAKAWA, H ;
ONODA, M ;
FUKUDA, H ;
SADAKI, H .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1986, 106 (06) :478-490